Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Endocrinology

Differential Diagnosis: Hyperthecosis vs. PCOS and Tumors

At a Glance

Ovarian stromal hyperthecosis is a rare source of high testosterone that differs from PCOS and can resemble a virilizing ovarian tumor. Testosterone, DHEA-S, symptom timing, imaging, and sometimes tissue examination help doctors identify the cause.

Evaluating elevated testosterone levels requires careful diagnostic work. Because ovarian stromal hyperthecosis (OH) is rare, it is often discussed in comparison to more common conditions like Polycystic Ovary Syndrome (PCOS) or more concerning possibilities like virilizing ovarian tumors (VOT) [1][2]. Understanding what your condition is and is not is an important step toward the right treatment.

Distinct from PCOS

While both hyperthecosis and PCOS involve the ovaries producing too much testosterone, they are distinct diagnoses [1].

  • PCOS is a common syndrome typically diagnosed during reproductive years. It often involves irregular periods, mild-to-moderate androgen symptoms, and characteristic ultrasound findings showing many small follicles (often mistakenly called cysts) on the ovaries. However, a person can have PCOS without this specific ovarian appearance [1][3].
  • Hyperthecosis is much rarer and is most often diagnosed after menopause [2]. Instead of follicles, it involves overactive nests of cells buried deep within the solid tissue (stroma) of the ovary [1].
  • The Testosterone Difference: In PCOS, testosterone levels are usually mildly to moderately elevated. In hyperthecosis, levels are frequently much higher, which can lead to more intense physical changes like a deepening voice or significant hair thinning [1][4].

Distinguishing Hyperthecosis from Ovarian Tumors

One of the most critical tasks for your medical team is evaluating for a virilizing ovarian tumor (VOT). These are rare tumors that secrete large amounts of androgens. They exhibit variable behavior, and some can be malignant [5].

Because the symptoms of hyperthecosis and tumors overlap substantially, doctors evaluate several overlapping clues. Note that no single test completely distinguishes the two without pathology:

Feature Ovarian Hyperthecosis Virilizing Ovarian Tumor
Speed of Onset Often slow; changes may happen over years [2]. Often rapid, but can vary [5].
Testosterone Level Elevated, but heavily overlaps with tumors [1]. Frequently very high (>150 ng/dL), overlapping heavily with hyperthecosis [6].
Imaging (MRI/US) Ovaries often appear normal or homogeneously (uniformly) enlarged [7]. May show a specific visible nodule, though small tumors can be occult (hidden) [7].

The Evaluation Pathway

It is standard practice for doctors to be highly thorough when evaluating marked testosterone elevations. They must ensure they do not miss an underlying tumor.

  1. Tumor Screening: If your testosterone is significantly elevated (e.g., above 145–150 ng/dL), most clinical guidelines recommend imaging (such as an MRI or CT scan) to evaluate the ovaries and adrenal glands for a mass [6][7].
  2. Adrenal Assessment: Your doctor will likely test a hormone called DHEA-S. If this is highly elevated, it suggests the hormones may be coming from an adrenal gland tumor rather than the ovaries, though a normal result does not absolutely exclude an adrenal source [8].
  3. The Definitive Answer: Because hyperthecosis or a small tumor might not show up on a scan, the only definitive way to confirm the tissue diagnosis is for a pathologist to examine the ovary tissue under a microscope, usually after surgical removal [1][7].

What This Means for You

Hyperthecosis is not a tumor, and it is a distinct condition from PCOS [1]. While the process of ruling out other conditions through lab draws and imaging can feel slow, it is necessary to ensure that your treatment plan safely addresses your exact condition.

Common questions in this guide

How is ovarian stromal hyperthecosis different from PCOS?
Both conditions can cause the ovaries to produce too much testosterone, but they are different diagnoses. PCOS is common and usually recognized during the reproductive years, while ovarian stromal hyperthecosis is rare, often diagnosed after menopause, and involves testosterone-producing cell nests within the ovarian stroma.
Can a testosterone result tell me whether I have hyperthecosis or an ovarian tumor?
No. Hyperthecosis and virilizing ovarian tumors can both cause very high testosterone, and levels above about 150 ng/dL can occur with either condition. Doctors combine the hormone level with symptom timing, imaging, and other tests rather than relying on one result.
What tests are used when testosterone is markedly high?
Doctors commonly order imaging, such as MRI or CT, to examine the ovaries and adrenal glands. They may also measure DHEA-S; a very high result suggests an adrenal source, although a normal result does not completely rule one out.
Can an ultrasound or MRI miss hyperthecosis or a small ovarian tumor?
Yes. In hyperthecosis, the ovaries may look normal or uniformly enlarged, and small tumors can be hidden on imaging. When scans do not provide an answer, microscopic examination of ovarian tissue, usually after surgical removal, may be needed for a definitive tissue diagnosis.
Does rapid onset of facial hair, voice changes, or hair loss mean I have a tumor?
Rapid progression raises concern for an androgen-secreting tumor, but it does not prove one because symptom speed can vary. Your clinician will interpret the timing alongside testosterone levels, imaging, and other tests.
Is ovarian hyperthecosis itself a tumor?
No. Ovarian hyperthecosis is a separate ovarian condition involving overactive nests of cells in the ovarian stroma. It can resemble an androgen-secreting tumor because both conditions may produce high testosterone, so careful evaluation is still important.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Why is my condition considered hyperthecosis rather than a form of PCOS?
  2. 2.How does my testosterone level compare to the thresholds you use to evaluate for an androgen-secreting tumor?
  3. 3.Do my imaging results show a specific growth or nodule, or are both ovaries uniformly affected or normal?
  4. 4.Given the speed of my symptom progression, how does that influence your level of concern for a tumor?
  5. 5.If my imaging is currently normal, how will we manage the possibility of a small tumor that might be difficult to see?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.

    Meczekalski B, Szeliga A, Maciejewska-Jeske M, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021; (37(8)):677-682 doi:10.1080/09513590.2021.1903419.

    PMID: 33759685
  2. 2

    Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis.

    Metzker LS, Ferreira LAC, Borges JCN, et al.

    Case reports in obstetrics and gynecology 2023; (2023()):2783464 doi:10.1155/2023/2783464.

    PMID: 36743832
  3. 3

    Sonographic evaluation of polycystic ovaries.

    Zhu RY, Wong YC, Yong EL

    Best practice & research. Clinical obstetrics & gynaecology 2016; (37()):25-37 doi:10.1016/j.bpobgyn.2016.02.005.

    PMID: 27118252
  4. 4

    Virilization, Ovarian Hyperthecosis, and Torsion Masquerading as Malignancy: A Case Report.

    Morrison A, Wassmer T, Swauger S, et al.

    Journal of pediatric and adolescent gynecology 2025; (38(3)):425-428 doi:10.1016/j.jpag.2024.12.005.

    PMID: 39653111
  5. 5

    Approach to androgen excess in women: Clinical and biochemical insights.

    Cussen L, McDonnell T, Bennett G, et al.

    Clinical endocrinology 2022; (97(2)):174-186 doi:10.1111/cen.14710.

    PMID: 35349173
  6. 6

    Dual case insights shaping a new protocol for post-menopausal hirsutism.

    Mohamed E, Sellicks J, Kitchener A, et al.

    JCEM case reports 2026; (4(6)):luag087 doi:10.1210/jcemcr/luag087.

    PMID: 42100586
  7. 7

    Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.

    Yance VRV, Marcondes JAM, Rocha MP, et al.

    European journal of endocrinology 2017; (177(1)):93-102.

    PMID: 28432270
  8. 8

    Rare Conditions of Hyperandrogenism Through Lifespan: A Case Series.

    Apostolopoulou M, Taayedi R, Sărac CP, Demtröder F

    Case reports in endocrinology 2025; (2025()):8604843 doi:10.1155/crie/8604843.

    PMID: 41358367

This page explains how clinicians distinguish ovarian stromal hyperthecosis from PCOS and androgen-secreting tumors for educational purposes. Your healthcare team must interpret your testosterone, imaging, and pathology results.

Get notified when new evidence is published on ovarian stromal hyperthecosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.